14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CYTR
Delisted

CytRx Corporation Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.0920
+0 (+0%)
At Close: Jan 27, 2023
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0920 $0.0920 Friday, 27th Jan 2023 CYTR stock ended at $0.0920. During the day the stock fluctuated 0% from a day low at $0.0920 to a day high of $0.0920.
90 days $0.0920 $0.0920
52 weeks $0.0520 $0.520

Historical CytRx Corporation prices

Date Open High Low Close Volume
Oct 10, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Oct 07, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Oct 06, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Oct 05, 2022 $0.0922 $0.100 $0.0900 $0.0920 4 048
Oct 04, 2022 $0.101 $0.101 $0.0920 $0.0920 8 935
Oct 03, 2022 $0.0950 $0.0990 $0.0850 $0.0910 48 962
Sep 30, 2022 $0.0850 $0.100 $0.0850 $0.0955 56 090
Sep 29, 2022 $0.0730 $0.0996 $0.0730 $0.0900 11 436
Sep 28, 2022 $0.0910 $0.0910 $0.0903 $0.0903 5 062
Sep 27, 2022 $0.0913 $0.110 $0.0913 $0.106 26 537
Sep 26, 2022 $0.0950 $0.120 $0.0950 $0.110 62 485
Sep 23, 2022 $0.100 $0.128 $0.100 $0.100 90 127
Sep 22, 2022 $0.117 $0.128 $0.0901 $0.128 74 338
Sep 21, 2022 $0.0867 $0.132 $0.0867 $0.120 18 299
Sep 20, 2022 $0.103 $0.132 $0.0934 $0.100 154 796
Sep 19, 2022 $0.125 $0.130 $0.111 $0.120 23 626
Sep 16, 2022 $0.125 $0.130 $0.102 $0.120 47 454
Sep 15, 2022 $0.0999 $0.125 $0.0929 $0.125 227 523
Sep 14, 2022 $0.0999 $0.0999 $0.0854 $0.0999 61 250
Sep 13, 2022 $0.0812 $0.0999 $0.0810 $0.0999 24 984
Sep 12, 2022 $0.0778 $0.100 $0.0778 $0.0999 44 761
Sep 09, 2022 $0.0999 $0.105 $0.0889 $0.0939 39 258
Sep 08, 2022 $0.0787 $0.0999 $0.0730 $0.0999 23 271
Sep 07, 2022 $0.0847 $0.0897 $0.0787 $0.0824 23 325
Sep 06, 2022 $0.0792 $0.0847 $0.0710 $0.0847 8 512
Click to get the best stock tips daily for free!

About CytRx Corporation

CytRx Corporation, a biopharmaceutical research and development company, focuses on oncology and rare diseases. It engages in the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor. The company's lead candidates include linker activated drug release (LADR) -7, LADR-8, LADR-9, and LADR-10; and A... CYTR Profile

Golden Star

Ticker Date Change Price
LPLA Apr 19 1.64% $262.59
MLI Apr 19 9.87% $52.28
LNG Apr 17 1.33% $156.81
FCN Apr 16 2.58% $207.62
ELV Apr 16 5.12% $506.97
DXC Apr 08 1.39% $20.87
ITCI Apr 05 8.14% $68.44
AKR Apr 05 6.84% $16.53
NSIT Apr 04 0.350% $185.62
VSTS Apr 04 0.638% $18.82
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT